Remdesivir | Dr Paul Marik | Global COVID Summit

Dec 18, 2021 Dr. Paul Marik on Remdesivir

Halfway through the study they did an interim analysis and found that the study was not going to be positive. So they changed the end point, the goal post, halfway through the study. That is called scientific misconduct.

Global COVID Summit, Nashville,
https://www.ntd.com/live-global-covid-summit-nashville-part-2_716402.html

Download on Telegram:
https://t.me/c19Videos/147